Mainz, Germany

Werner Krame

This inventor holds 3 USPTO granted patents. Top assignees: Sanofi-A Ventis Deutschland Gmbh, Aventis Pharma Deutschland, Gmbh. Active years: 2006-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Werner Krame. Retrieved from https://idiyas.com/inventor/werner-krame

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2006-2009

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Werner Krame: Innovator in Medicinal Chemistry

Introduction

Werner Krame is a notable inventor based in Mainz-Laubenheim, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on diphenylazetidinones. With a total of 3 patents, Krame's inventions have the potential to impact the pharmaceutical industry positively.

Latest Patents

Krame's latest patents focus on diphenylazetidinones, detailing a process for their preparation and the development of medicaments comprising these compounds. The compounds are characterized by the formula I, where R1, R2, R3, R4, R5, and R6 have specific meanings as described in the patent documentation. These compounds are particularly suitable for use as hypolipidemics, offering potential therapeutic benefits.

Career Highlights

Throughout his career, Krame has worked with prominent companies in the pharmaceutical sector, including Sanofi-Aventis Deutschland GmbH and Aventis Pharma Deutschland GmbH. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Krame has collaborated with several professionals in his field, including Heiner Glombik and Stefanie Flohr. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Werner Krame's contributions to medicinal chemistry through his patents on diphenylazetidinones highlight his innovative spirit and dedication to improving health outcomes. His work continues to influence the pharmaceutical industry and showcases the importance of research and collaboration in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…